Vistaar · Newsroom

VISTAAR is empowering Biopharma & Device teams with Product & Label Intel modules
Vistaar’s enhanced Product Analytics & Label Intelligence modules to enable researchers find deep insights of approved/marketed products for development and commercial needs

November 12, 2020

VISTAAR added more AI capabilities to Clinical Insights
Clinical trial intelligence and insights from VISTAAR enables clinical teams to find deeper insights to design and plan clinical trials better

April 24, 2020

ClinIntel – VISTAAR’s New Feature Addressing Global Clinical Trials
VISTAAR, an AI enabled clinical and regulatory intelligence tool, moves ahead and introduces its new feature – ClinIntel in its attempt to address the needs in clinical trials through the management of real life scenarios.

November 1, 2019

VISTAAR Announces Addition of “ADVISORY Playbooks” to it’s Regulatory & Clinical Intelligence Platform
VISTAAR expands its AI based Biopharma and Medical Devices Intelligence Technology to make it more Efficient and Cost-effective for Companies

September 25, 2019

DDi Launches VISTAAR.ai to Accelerate Regulatory and Clinical Intelligence
Leveraging artificial intelligence, technology provides comprehensive coverage and actionable insights on global regulatory information for drugs, biologics, and devices of about 90 countries.

April 8, 2019